Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

about

Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.

P2860

Q27853196-932B2738-EE99-4D55-9558-6F1D711777AB

P2860

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

Item

http://www.wikidata.org/entity/Q40226279

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

@en

type

Item

label

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

@en

prefLabel

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

@en

P1476

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

@en

P2093

Ants Toi

http://www.w3.org/2001/XMLSchema#string

Changhong Yu

http://www.w3.org/2001/XMLSchema#string

John Trachtenberg

http://www.w3.org/2001/XMLSchema#string

Raj Satkunasivam

http://www.w3.org/2001/XMLSchema#string

Robert K Nam

http://www.w3.org/2001/XMLSchema#string

Steven A Narod

http://www.w3.org/2001/XMLSchema#string

William Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.

The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies.

Decision curve analysis: a novel method for evaluating prediction models

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range.

P2888

2193-1801-3-295

P304

295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2193-1801-3-295

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eleftherios P. Diamandis

Michael W Kattan

P577

2014-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266401273

http://www.w3.org/2001/XMLSchema#string

P6179

1023205138

http://www.w3.org/2001/XMLSchema#string

P698

25279276

http://www.w3.org/2001/XMLSchema#string

P932

4162525

http://www.w3.org/2001/XMLSchema#string

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

about

P2860

P2860

Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932